delP GC13, DJ-1-delP GC13
LCSBi008-A-1
General#
Cell Line |
|
hPSCreg Name | LCSBi008-A-1 |
Alternative name(s) |
delP GC13, DJ-1-delP GC13
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Last update | 4th April 2022 |
User feedback | |
Provider |
|
Generator | Luxembourg Centre for Systems Biomedicine (LCSB) |
External Databases |
|
BioSamples | SAMEA13914317 |
General Information |
|
Publications | |
* Is the cell line readily obtainable for third parties? |
No |
Subclone of |
Donor Information#
General Donor Information |
|
Sex | male |
Phenotype and Disease related information (Donor) |
|
Diseases | A disease was diagnosed.
|
External Databases (Donor) |
|
BioSamples | SAMEA13793663 |
Ethics#
Also have a look at the ethics information for the parental line
LCSBi008-A
.
Is there an MTA available for the cell line? | No |
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation#
General |
|
The source cell information can be found in the parental cell line
LCSBi008-A.
|
|
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Episomal |
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
Unknown |
Derived under GMP? |
Unknown |
Available as clinical grade? |
Unknown |
Culture Conditions#
Medium |
Essential 8™
|
Characterisation#
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | FACS | Enzymatic Assay | Expression Profiles |
NANOG |
Yes |
|
|
|||
SOX2 |
Yes |
|
||||
POU5F1 (OCT-4) |
Yes |
|
|
|||
DNMT3B |
Yes |
|
Microbiology / Virus Screening |
|
Mycoplasma | Negative |
Genotyping#
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
46XY
|
Other Genotyping (Cell Line) |
Genetic Modification#
Disease/phenotype related modifications |
|
Genetic modifications not related to a disease |
|
Login to share your feedback, experiences or results with the research community.